Drug Profile
Research programme: abuse resistant therapeutics - Inspirion Delivery Technologies
Alternative Names: Oxycodone ER; Research programme: abuse deterrent therapeutics - InspirionLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Inspirion Delivery Technologies
- Class
- Mechanism of Action Adrenergic receptor agonists; Dopamine receptor agonists; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Attention-deficit hyperactivity disorder; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Attention-deficit-hyperactivity-disorder in USA (PO, Controlled release)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA (PO, Controlled release)
- 28 Sep 2009 Preclinical trials in Attention-deficit hyperactivity disorder in USA (PO)